General Information of This Metabolic Reaction (MR) (ID: MR013615)
Formula Reactant NITD609 Metabolite M23 Product NITD609 Metabolite M21.8,M23.5A
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013613 NITD609 Metabolite M18 NITD609 Metabolite M23 Unclear NITD609 [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013614 NITD609 Metabolite M23 NITD609 Metabolite M16 Unclear NITD609 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013616 NITD609 Metabolite M14,M24,M32 NITD609 Metabolite M21.8,M23.5A Unclear NITD609 [1]
References
1 KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.